DST-0509 (Deferasirox)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DST-0509 (Deferasirox), covering 2022-02-01 to 2022-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation [Phase 2]